Evidence map›Paper›PMID 38491376›Full record

ArticleImplementation science communications2024

Assessing the implementation of a multi-component hypertension program in a Guatemalan under-resourced dynamic context: an application of the RE-AIM/PRISM extension for sustainability and health equity.

Alejandra Paniagua-Avila, Rachel C Shelton, Juan Carlos Figueroa, Ana Lissette Guzman, Laura Gutierrez, Diego Rolando Hernandez-Galdamez, Juan Manuel Ramirez, Javier Rodriguez, Vilma Irazola, Manuel Ramirez-Zea and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Implementation science communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03504124 (Implementing a Multicomponent Intervention to Improve Hypertension Control in Central America), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03504124 phase3completednot on this map

Implementing a Multicomponent Intervention to Improve Hypertension Control in Central America

TypeinterventionalSponsorInstitute of Nutrition of Central America and PanamaRan2019 to 2022Enrolled1,854ConditionsArterial HypertensionArmsMulticomponent intervention
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Alejandra Paniagua-AvilaEpidemiology Department, Mailman School of Public Health, Columbia University, New York, NY, USA. malejandrapaniagua@gmail.com.ORCID http://orcid.org/0000-0002-1152-3785
Rachel C SheltonDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
Juan Carlos FigueroaINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala.
Ana Lissette GuzmanINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala.
Laura GutierrezInstitute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
Diego Rolando Hernandez-GaldamezINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala.
Juan Manuel RamirezINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala.
Javier RodriguezINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala.
Vilma IrazolaInstitute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
Manuel Ramirez-ZeaINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala.
Meredith P FortINCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala.

Funding

RESEARCH TRAINING PROGRAM IN PSYCHIATRIC EPIDEMIOLOGYT32MH013043 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Katherine M. Keyes · 1985 to 2026
$11.7M
IMPlementation to Achieve Clinical Transformation (IMPACT): The Colorado Training ProgramK12HL137862 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GLASGOW, RUSSELL E, HAVRANEK, EDWARD PAUL · 2017 to 2021
$2.9M
Implementing a Multicomponent Intervention to Improve Hypertension Control in Central AmericaU01HL138647 · NHLBI · INSTITUTE/NUTRITION/CENT/AMERICA/PANAMA · PI HE, JIANG, RAMIREZ-ZEA, MANUEL · 2017 to 2021
$1.6M
NHLBI NIH HHS 5K12HL137862NHLBI NIH HHS K12 HL137862NHLBI NIH HHS U01 HL138647NHLBI NIH HHS U01HL138647NIMH NIH HHS T32 MH013043
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic necessitated rapid changes in healthcare delivery in Guatemala's public primary care settings. A new hypertension program, implemented as part of a type 2 hybrid trial since 2019, exemplifies an implementation effort amidst a changing context in an under-resourced setting. We assessed the implementation of an evidence-based intervention (EBI; protocol-based hypertension treatment) and one of its main implementation strategies (team-based collaborative care), raising implications for health equity and sustainability. We present innovative application of systems thinking visuals.

methodsConducting a convergent mixed methods analysis, we assessed implementation in response to contextual changes across five Ministry of Health (MoH) districts at the pandemic's onset. Utilizing quantitative programmatic data and qualitative interviews with stakeholders (n=18; health providers, administrators, study staff), we evaluated dimensions of "Reach, Effectiveness, Adoption, Implementation and Maintenance," RE-AIM (Reach, Implementation delivery + adaptations), and "Practical Robust Implementation and Sustainability Model," PRISM (Organizational perspective on the EBI, Fit, Implementation and sustainability infrastructure) frameworks. We assessed representativeness by comparing participants to census data. To assess implementation delivery, we built behavior-over-time (BOT) graphs with quantitative programmatic data (July 2019-July 2021). To assess adaptations and contextual changes, we performed matrix-based thematic qualitative analysis. We converged quantitative implementation delivery data + qualitative adaptations data in joint displays. Finally, we analyzed qualitative and quantitative results across RE-AIM/PRISM and health districts to identify equity and sustainability considerations.

resultsContextual factors that facilitated program delivery included the perception that the EBI was beneficial, program champions, and staff communication. Key barriers to implementation delivery included competition with other primary care activities and limited implementation infrastructure (e.g., equipment, medications). Contextual changes related to COVID-19 hindered implementation delivery, threatened sustainability, and may have exacerbated inequities. However, adaptations that were planned enhanced implementation delivery and may have supported improved equity and sustainability.

conclusionsRecognition of an EBI's benefits and program champions are important for supporting initial uptake. The ability to plan adaptations amid rapid contextual changes has potential advantages for sustainability and equitable delivery. Systems thinking tools and mixed methods approaches may shed light on the relations between context, adaptations, and equitable and sustainable implementation.

trial registrationNCT03504124.

Indexed as

AdaptationsDynamic contextHealth equityHybrid trialHypertensionImplementation scienceLatin AmericaLow- and middle-income countriesMixed methodsRE-AIM/PRISMSustainability

Identifiers

PMID38491376
PMCPMC10941412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.